
Venture Capital & Emerging Companies
Viewpoints
Filter by:
MintzTech Connect: All Things Technology — May 2023
May 24, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
MintzTech Connect Industry News: Spotlight on Coefficient
May 24, 2023 | Article | By Daniel DeWolf
Benefits and Legal Risks of Embracing Generative AI Applications
April 5, 2023 | Blog | By Jeremy Glaser, Lorena Niebla
Generative artificial intelligence creates content and work efficiencies but also comes with legal pitfalls. Mintz Venture Capital & Emerging Companies Practice Co-chair Jeremy Glaser and Associate Lorena Niebla look at the technology's potential uses as well as risks related to data privacy, intellectual property, and more.
Read more
MintzTech Connect: All Things Technology — February 2023
February 21, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
MintzTech Connect Industry News: Spotlight on Moolah Kicks
February 15, 2023 | Article | By Daniel DeWolf
Mintz Venture Watch — Volume 4: A Report on Deal Trends from 2022
February 9, 2023 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Extending for Success: The Rising Trend of Extension Rounds and the Importance of Due Diligence
January 11, 2023 | Article | By Jeremy Glaser, Roman M. Gorokhov, Will Perkins
MintzTech Connect Industry News: Spotlight on Ben Zises and SuperAngel.Fund
December 7, 2022 | Article | By Daniel DeWolf
MintzTech Connect: All Things Technology — December 2022
December 7, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
OpEd: Top Five Ways to Accelerate Growth of Emerging Companies
October 21, 2022 | Blog
Mintz Leads For Axoft In $8 Million Seed Round Demonstrating Continued Dedication To Biotech Start-Up Market
October 19, 2022
Mintz represented Axoft, a neurotechnology company, in its $8 million seed round led by The Engine, a venture firm spun out of MIT that invests in early-stage Tough Tech companies.
MintzTech Connect Industry News: Spotlight on Adgile Media Group
September 19, 2022 | Article | By Daniel DeWolf
MintzTech Connect Industry News: Spotlight on Radicle Science
September 19, 2022 | Article | By Jeremy Glaser
MintzTech Connect: All Things Technology — September 2022
September 19, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
Mintz Venture Watch — Volume 3: A Report on Deal Trends from Q1 and Q2 2022
August 17, 2022 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Amendment to Delaware Law Permits Exculpation of Officers in Corporate Charters
August 15, 2022 | Advisory | By Daniel A. Lerner
Is a Public Benefit Corporation Right for Your Mission-Driven Business?
July 18, 2022 | Article | By Kati P. Strzelczyk
Read an analysis of the differences between public benefit corporations and traditional corporations and issues for founders of mission-driven business to consider when deciding on a corporate structure.
Read more
MintzTech Connect: All Things Technology — May 2022
May 25, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
MintzTech Connect Industry News: Spotlight on YUR Inc.
May 25, 2022 | Article | By Daniel DeWolf, Samuel Asher Effron
Six Common Contract Traps: A Field Guide
March 25, 2022 | Advisory | By Alex Civetta
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment, Labor & Benefits
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology